Structure-oriented review of 14-3-3 protein isoforms in geriatric neuroscience
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure-oriented review of 14-3-3 protein isoforms in geriatric neuroscience
Authors
Keywords
-
Journal
Geriatrics & Gerontology International
Volume 12, Issue 4, Pages 586-599
Publisher
Wiley
Online
2012-06-05
DOI
10.1111/j.1447-0594.2012.00860.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Isoform-specific immunolocalization of 14-3-3 proteins in atherosclerotic lesions of human carotid and main cerebral arteries
- (2012) Takahiko Umahara et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Differential expression of 14-3-3 protein isoforms in developing rat hippocampus, cortex, rostral migratory stream, olfactory bulb, and white matter
- (2011) Takahiko Umahara et al. BRAIN RESEARCH
- Structural basis of 14-3-3 protein functions
- (2011) Tomas Obsil et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- 14-3-3 Proteins and Spinocerebellar Ataxia Type 1: from Molecular Interaction to Human Neuropathology
- (2010) Takahiko Umahara et al. CEREBELLUM
- New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?
- (2010) Wei Deng et al. NATURE REVIEWS NEUROSCIENCE
- Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease
- (2010) T A Yacoubian et al. Cell Death & Disease
- Peroxisome Proliferator-Activated Receptors Protect against Apoptosis via 14-3-3
- (2010) Kenneth K. Wu PPAR Research
- Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3ζ protein
- (2009) Golam Sadik et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effect of phosphorylation on interaction of human tau protein with 14-3-3ζ
- (2009) Nikolai N. Sluchanko et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ligand-Activated Peroxisome Proliferator–Activated Receptor-γ Protects Against Ischemic Cerebral Infarction and Neuronal Apoptosis by 14-3-3ε Upregulation
- (2009) Jui-Sheng Wu et al. CIRCULATION
- Phosphorylation of more than one site is required for tight interaction of human tau protein with 14-3-3ζ
- (2009) Nikolai N. Sluchanko et al. FEBS LETTERS
- Propagation of Tau Misfolding from the Outside to the Inside of a Cell
- (2009) Bess Frost et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Isoform-dependent immunolocalization of 14-3-3 proteins in developing rat cerebellum
- (2008) Takahiko Umahara et al. BRAIN RESEARCH
- Tau Oligomerization: A Role for Tau Aggregation Intermediates Linked to Neurodegeneration
- (2008) N. Sahara et al. Current Alzheimer Research
- 14-3-3 Zeta and Tau Genes Interactively Decrease Alzheimer’s Disease Risk
- (2008) Ignacio Mateo et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Gene–gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer's disease risk
- (2008) I. Mateo et al. EUROPEAN JOURNAL OF NEUROLOGY
- Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery
- (2008) Yan Wang et al. FASEB JOURNAL
- Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation
- (2008) Golam Sadik et al. JOURNAL OF NEUROCHEMISTRY
- Late onset Huntington Disease: Clinical and genetic characteristics of 34 cases
- (2008) Hillary Lipe et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Ischemic preconditioning suppresses apoptosis of rabbit spinal neurocytes by inhibiting ASK1–14-3-3 dissociation
- (2008) Chengwei Yang et al. NEUROSCIENCE LETTERS
- 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein
- (2007) Kazuya Omi et al. NEUROSCIENCE LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started